Advantage Trust CO Spdr Ser Tr Spdr S&P Biotech E Transaction History

Advantage Trust CO

$221 Billion
Q3 2025

A detailed history of Advantage Trust CO transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Advantage Trust CO holds 4,245 shares of XBI stock, worth $483,972. This represents 0.19% of its overall portfolio holdings.

Number of Shares

4,245

Previous 4,245 -0.0%

Holding current value

$483,972

Previous $352 Million 20.83%

% of portfolio

0.19%

Previous 0.17%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	BUY	$69.8 - $85.28 $34,900 - $42,640	500 Added 13.35%	4,245 $352 Million
Q1 2025 May 07, 2025	SELL	$81.1 - $94.7 $72,990 - $85,230	-900 Reduced 19.38%	3,745 $304 Million
Q4 2024 Feb 03, 2025	SELL	$89.81 - $104.0 $107,772 - $124,800	-1,200 Reduced 20.53%	4,645 $418 Million
Q3 2024 Nov 04, 2024	SELL	$90.87 - $102.43 $54,522 - $61,458	-600 Reduced 9.31%	5,845 $577 Million
Q4 2023 Feb 07, 2024	BUY	$64.12 - $90.86 $413,253 - $585,592	6,445 New	6,445 $575 Million

Others Institutions Holding XBI

# of Institutions

836

Shares Held

121M

Call Options Held

28.4M

Put Options Held

34.2M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advantage Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Advantage Trust CO with notifications on news.

Account

Advantage Trust CO Spdr Ser Tr Spdr S&P Biotech E Transaction History